000143475 001__ 143475
000143475 005__ 20240229112553.0
000143475 0247_ $$2doi$$a10.3390/nu11030544
000143475 0247_ $$2pmid$$apmid:30836637
000143475 0247_ $$2altmetric$$aaltmetric:57455661
000143475 037__ $$aDKFZ-2019-01063
000143475 041__ $$aeng
000143475 082__ $$a610
000143475 1001_ $$0P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aSchübel, Ruth$$b0$$eFirst author$$udkfz
000143475 245__ $$aSimilar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD.
000143475 260__ $$aBasel$$bMDPI$$c2019
000143475 3367_ $$2DRIVER$$aarticle
000143475 3367_ $$2DataCite$$aOutput Types/Journal article
000143475 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1555418980_10187
000143475 3367_ $$2BibTeX$$aARTICLE
000143475 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143475 3367_ $$00$$2EndNote$$aJournal Article
000143475 520__ $$aPreliminary evidence suggests that weight loss among obese has differential metabolic effects depending on the presence of non-alcoholic fatty liver disease (NAFLD). We assessed whether NAFLD predisposes to differential changes in liver fat content, liver function, and metabolic parameters upon diet-induced weight loss in a 50-week intervention trial.143 overweight and obese non-smokers underwent a 12-week dietary intervention and a 38-week follow-up. Diet-induced changes in anthropometric measures, circulating biomarkers, and magnetic resonance (MR)-derived liver fat content and adipose tissue volumes were evaluated by mixed linear models stratifying by NAFLD at baseline.The prevalence of NAFLD at baseline was 52%. Diet-induced weight loss after 12 (NAFLD: 4.8 ± 0.5%, No NAFLD: 5.1 ± 0.5%) and 50 weeks (NAFLD: 3.5 ± 0.7%, No NAFLD: 3.5 ± 0.9%) was similar in both groups, while the decrease in liver fat was significantly greater in the NAFLD group (week 12: 32.9 ± 9.5% vs. 6.3 ± 4.0%; week 50: 23.3 ± 4.4% vs. 5.0 ± 4.2%). Decreases in biomarkers of liver dysfunction (GGT, ALT, AST) and HOMA IR were also significantly greater in the NAFLD group. Other metabolic parameters showed no significant differences.Our data suggest that individuals with NAFLD show greater improvements of liver function and insulin sensitivity after moderate diet-induced weight loss than individuals without NAFLD.
000143475 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000143475 588__ $$aDataset connected to CrossRef, PubMed,
000143475 7001_ $$aNonnenmacher, Tobias$$b1
000143475 7001_ $$0P:(DE-He78)fd4ffe2a3f08e0158b82400acd6716be$$aSookthai, Disorn$$b2$$udkfz
000143475 7001_ $$0P:(DE-HGF)0$$aGonzalez Maldonado, Sandra$$b3
000143475 7001_ $$0P:(DE-HGF)0$$aSowah, Solomon A$$b4
000143475 7001_ $$avon Stackelberg, Oyunbileg$$b5
000143475 7001_ $$aSchlett, Christopher L$$b6
000143475 7001_ $$0P:(DE-HGF)0$$aGrafetstätter, Mirja$$b7
000143475 7001_ $$0P:(DE-He78)88b0447328f114c763ebba2ef70f680c$$aNabers, Diana$$b8$$udkfz
000143475 7001_ $$0P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aJohnson, Theron Scot$$b9$$udkfz
000143475 7001_ $$aKirsten, Romy$$b10
000143475 7001_ $$00000-0001-7641-059X$$aUlrich, Cornelia M$$b11
000143475 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b12$$udkfz
000143475 7001_ $$aKauczor, Hans-Ulrich$$b13
000143475 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b14$$udkfz
000143475 7001_ $$aNattenmüller, Johanna$$b15
000143475 773__ $$0PERI:(DE-600)2518386-2$$a10.3390/nu11030544$$gVol. 11, no. 3, p. 544 -$$n3$$p544 $$tNutrients$$v11$$x2072-6643$$y2019
000143475 909CO $$ooai:inrepo02.dkfz.de:143475$$pVDB
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd4ffe2a3f08e0158b82400acd6716be$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)88b0447328f114c763ebba2ef70f680c$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000143475 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000143475 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000143475 9141_ $$y2019
000143475 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNUTRIENTS : 2017
000143475 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143475 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143475 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143475 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000143475 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000143475 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000143475 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000143475 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000143475 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143475 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143475 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143475 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143475 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143475 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebserkrankungen$$x0
000143475 9201_ $$0I:(DE-He78)E130-20160331$$kE130$$lComputer-assistierte medizinische Interventionen$$x1
000143475 980__ $$ajournal
000143475 980__ $$aVDB
000143475 980__ $$aI:(DE-He78)C020-20160331
000143475 980__ $$aI:(DE-He78)E130-20160331
000143475 980__ $$aUNRESTRICTED